Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin.

H, Suzuki; M, Terai; H, Hamada; T, Honda; T, Suenaga; T, Takeuchi; N, Yoshikawa; S, Shibuta; M, Miyawaki; K, Oishi; H, Yamaga; N, Aoyagi; S, Iwahashi; R, Miyashita; Y, Onouchi; K, Sasago; Y, Suzuki; A, Hata

doi:10.1097/inf.0b013e318220c3cf

Public

Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin.

Shared by NobleBlocks on Oct 1, 2011 • 12:00 AM UTC

Authors:

Suzuki H

Terai M

Hamada H

Abstract

<h4>Background</h4>There are still no definite treatments for refractory Kawasaki disease (KD). In this pilot study, we evaluated the use of cyclosporin A (CyA) treatment in patients with refractory KD.<h4>Methods</h4>We prospectively collected clinical data of CyA treatment (4-8 mg/kg/d, oral admin...

Discussions